Kaplan-Meier curves showing prognostic impact of sCD163 levels in the 2 cohorts. Probability of (A) PFS and (B) OS by sCD163 level (dichotomized by median level 3211 ng/mL) in patients newly diagnosed with MCL. Five-year OS was 97% vs 51% in patients with low sCD163 vs high sCD163. (C) probability of PFS and (D) Probability of OS by sCD163 level (dichotomized by median level 2963 ng/mL) in patients with relapsed MCL.